TW460478B - Phenethylamine derivatives - Google Patents

Phenethylamine derivatives Download PDF

Info

Publication number
TW460478B
TW460478B TW087113211A TW87113211A TW460478B TW 460478 B TW460478 B TW 460478B TW 087113211 A TW087113211 A TW 087113211A TW 87113211 A TW87113211 A TW 87113211A TW 460478 B TW460478 B TW 460478B
Authority
TW
Taiwan
Prior art keywords
tbu
tyr
group
phe
quot
Prior art date
Application number
TW087113211A
Other languages
English (en)
Chinese (zh)
Inventor
Kenichiro Kotake
Toshiro Kozono
Tsutomu Sato
Hisanori Takanashi
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of TW460478B publication Critical patent/TW460478B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
TW087113211A 1997-08-15 1998-08-11 Phenethylamine derivatives TW460478B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25587997 1997-08-15
JP18680298 1998-05-28

Publications (1)

Publication Number Publication Date
TW460478B true TW460478B (en) 2001-10-21

Family

ID=26503986

Family Applications (1)

Application Number Title Priority Date Filing Date
TW087113211A TW460478B (en) 1997-08-15 1998-08-11 Phenethylamine derivatives

Country Status (10)

Country Link
US (1) US6255285B1 (US06255285-20010703-C00102.png)
EP (1) EP1006122B1 (US06255285-20010703-C00102.png)
KR (1) KR20010022924A (US06255285-20010703-C00102.png)
CN (1) CN1272114A (US06255285-20010703-C00102.png)
AT (1) ATE416186T1 (US06255285-20010703-C00102.png)
AU (1) AU741216B2 (US06255285-20010703-C00102.png)
CA (1) CA2301687A1 (US06255285-20010703-C00102.png)
DE (1) DE69840296D1 (US06255285-20010703-C00102.png)
TW (1) TW460478B (US06255285-20010703-C00102.png)
WO (1) WO1999009053A1 (US06255285-20010703-C00102.png)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0639374T3 (da) * 1993-06-28 2002-05-06 American Home Prod Nye behandlingsmetoder ved anvendelse af phenethylderivater
US6329372B1 (en) * 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
TW509699B (en) * 1998-09-24 2002-11-11 Chugau Pharmaceutical Co Ltd Ethylamine derivatives
WO2000044770A1 (fr) * 1999-01-28 2000-08-03 Chugai Seiyaku Kabushiki Kaisha Derives phenethylamine substitues
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6511980B2 (en) 2000-05-05 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Substituted diamine derivatives useful as motilin antagonists
GB0030304D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
EP1312612A4 (en) * 2000-08-24 2004-09-22 Chugai Pharmaceutical Co Ltd CYCLIC PEPTIDE DERIVATIVE
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
WO2002057791A2 (en) * 2000-11-29 2002-07-25 Lifespan Biosciences, Inc. Diagnostic and therapeutic compositions and methods related to grp 38
WO2002059141A1 (fr) * 2001-01-25 2002-08-01 Chugai Seiyaku Kabushiki Kaisha Derives peptidiques
CA2442654A1 (en) * 2001-04-10 2002-10-10 Transtech Pharma, Inc. Probes, systems, and methods for drug discovery
TNSN03146A1 (fr) * 2001-06-28 2005-12-23 Pfizer Prod Inc Indoles, benzofurannes et benzothiophenes a substituant triamide, utiles comme inhibiteurs de secretion de la proteine de transfert des triglycerides microsomaux et/ou de l'apolipo-proteine b (apo b).
US7338939B2 (en) * 2003-09-30 2008-03-04 New River Pharmaceuticals Inc. Abuse-resistant hydrocodone compounds
US7375082B2 (en) * 2002-02-22 2008-05-20 Shire Llc Abuse-resistant hydrocodone compounds
US20070066537A1 (en) * 2002-02-22 2007-03-22 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) * 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7169752B2 (en) * 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
CN1939529A (zh) * 2002-01-29 2007-04-04 Wyeth公司 用于调节连接蛋白半通道的组合物和方法
CA2477004C (en) * 2002-02-22 2011-05-10 Thomas Piccariello Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
EP1481078A4 (en) * 2002-02-22 2006-08-16 New River Pharmaceuticals Inc USE OF A PEPTIDE DRUG CONJUGATION TO REDUCE VARIABILITY OF MEDICAMENT SERUM MIRRORS BETWEEN PATIENTS
SI1644019T2 (en) * 2003-05-29 2018-04-30 Shire Llc AMPHETAMINE COMPOUNDS COMPOUNDS TO ABUSE
JP4928261B2 (ja) 2003-06-18 2012-05-09 トランザイム・ファーマ・インコーポレイテッド モチリン受容体の大環状拮抗薬
BRPI0414876A (pt) * 2003-09-30 2006-11-21 New River Pharmaceuticals Inc compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
EP2431380A3 (en) 2006-09-11 2013-07-03 Tranzyme Pharma, Inc. Macrocyclic antagonist of the motilin receptor for treatment of gastrointestinal dysmotility disorders
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
KR20180084782A (ko) 2015-10-14 2018-07-25 엑스-써마 인코포레이티드 얼음 결정 형성을 감소시키기 위한 조성물 및 방법
CN112812334B (zh) * 2021-01-11 2022-06-17 浙江博菲电气股份有限公司 一种新能源电机用阻燃槽楔的制备工艺及阻燃槽楔

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003483A1 (en) 1992-07-30 1994-02-17 Chiron Corporation Endothelin receptor-binding compounds
US5470830A (en) 1993-08-06 1995-11-28 Ohmeda Pharmaceutical Products Division Inc. Motilin-like polypeptides that inhibit gastrointestinal motor activity
JP3449766B2 (ja) 1993-11-19 2003-09-22 中外製薬株式会社 モチリンアンタゴニスト
WO1996040208A1 (en) * 1995-06-07 1996-12-19 Torrey Pines Institute For Molecular Studies Novel mu opioid receptor ligands: agonists and antagonists
US5712253A (en) 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B
US6013633A (en) * 1997-08-07 2000-01-11 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
US5972939A (en) 1997-10-28 1999-10-26 Ortho-Mcneil Pharmaceutical, Inc. Cyclopentene derivatives useful as antagonists of the motilin receptor
WO2000044770A1 (fr) * 1999-01-28 2000-08-03 Chugai Seiyaku Kabushiki Kaisha Derives phenethylamine substitues

Also Published As

Publication number Publication date
EP1006122A4 (en) 2004-10-13
AU8649098A (en) 1999-03-08
EP1006122A1 (en) 2000-06-07
CN1272114A (zh) 2000-11-01
US6255285B1 (en) 2001-07-03
DE69840296D1 (de) 2009-01-15
ATE416186T1 (de) 2008-12-15
AU741216B2 (en) 2001-11-29
KR20010022924A (ko) 2001-03-26
EP1006122B1 (en) 2008-12-03
WO1999009053A1 (fr) 1999-02-25
CA2301687A1 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
TW460478B (en) Phenethylamine derivatives
TW492955B (en) Inhibitors of protein isoprenyl transferases
TW577895B (en) Hepatitis C inhibitor peptides
TWI247748B (en) Peptide antiangiogenic drugs
TWI386417B (zh) 轉移抑素衍生物及其用途
DK147851B (da) Nonapeptidamidderivater til brug ved diagnosticering af hypofysefunktionog gonadotropindeficiens samt regulering af formeringen hos normale dyr
CN109689112A (zh) 化学选择性的巯基与烯基或炔基磷酰胺的偶联
JP2018512415A (ja) エテルカルセチドの調製のための液相方法
US6235876B1 (en) Liquid phase process for the preparation of GNRH peptides
IE45576B1 (en) Analgesic tetrapeptides and pentapeptides
IE921689A1 (en) Terminally modified tri-, tetra- and pentapeptide¹anaphylatoxin receptor ligands
CZ100693A3 (en) Non-peptidic antagonists of bembesin
EP1179537B1 (en) Solid phase peptide synthesis method
JPH05310784A (ja) ヒト乳頭腫ウイルスタンパク質と網膜芽細胞腫遺伝子タンパク質との結合のペプチド阻害剤
JPS58116443A (ja) 新規ペプチドおよびその製法
Nicolás et al. A new approach to Hmb-backbone protection of peptides: synthesis and reactivity of Nα-Fmoc-Nα-(Hmb) amino acids
JPH06504050A (ja) 改質ヘキサ−及びヘプタ−ペプチドアナフィラトキシン受容体リガンド
WO2006025536A1 (ja) 抗sarsウイルス剤
HU182866B (en) Process for preparing new tetrapeptide derivatives
JPH07505865A (ja) ボンベシンのフェニルアラニン類似体類
JP2003073396A (ja) ペプチドの製造方法
HU185229B (en) Process for preparing pharmaceutically active peptides and acetates thereof
JPS6220200B2 (US06255285-20010703-C00102.png)
WO2014119753A4 (ja) マイオスタチン阻害ペプチド
JP3583928B2 (ja) フェネチルアミン誘導体

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees